Laddar...
Cross-Presenting XCR1(+) Dendritic Cells as Targets for Cancer Immunotherapy
The use of dendritic cells (DCs) to generate effective anti-tumor T cell immunity has garnered much attention over the last thirty-plus years. Despite this, limited clinical benefit has been demonstrated thus far. There has been a revival of interest in DC-based treatment strategies following the re...
Sparad:
| I publikationen: | Cells |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7140519/ https://ncbi.nlm.nih.gov/pubmed/32121071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030565 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|